TC
SGYP

TFS Capital’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

TFS Capital’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,236
Closed -$65K – 1476
2014
Q1 		$65K Sell
12,236
-9,841
-45% -$55.2K ﹤0.01% 1302
2013
Q4 		$123K Buy
+22,077
New +$95.2K 0.01% 1378
2013
Q3 		– Sell
-207,680
Closed -$885K – 1722
2013
Q2 		$885K Buy
+207,680
New +$1.04M 0.04% 652

Other funds holding SGYP

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

TFS Capital's SGYP Position: Q2 2014 in Review

TFS Capital sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2014, closing a stake of 12,236 shares — an estimated $65K sold.

TFS Capital first reported a position in SGYP in Q2 2013 and held it in 3 quarters. The position peaked at $885K in Q2 2013. 86 funds tracked by Wall St. Rank hold SGYP as of Q2 2014.

  • TFS Capital reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2014 after selling out during the quarter.
  • TFS Capital sold 12,236 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2014, an estimated $65K.
  • TFS Capital first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 3 quarters.
  • TFS Capital's Synergy Pharmaceuticals, Inc Common Stock position peaked at $885K in Q2 2013.
  • 86 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2014.

Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.